437 related articles for article (PubMed ID: 26283490)
21. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
[TBL] [Abstract][Full Text] [Related]
22. Linear accelerator based stereotactic radiosurgery for melanoma brain metastases.
Bernard ME; Wegner RE; Reineman K; Heron DE; Kirkwood J; Burton SA; Mintz AH
J Cancer Res Ther; 2012; 8(2):215-21. PubMed ID: 22842364
[TBL] [Abstract][Full Text] [Related]
23. Initial clinical experience with frameless radiosurgery for patients with intracranial metastases.
Kamath R; Ryken TC; Meeks SL; Pennington EC; Ritchie J; Buatti JM
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1467-72. PubMed ID: 15817352
[TBL] [Abstract][Full Text] [Related]
24. Risk of leptomeningeal disease in patients treated with stereotactic radiosurgery targeting the postoperative resection cavity for brain metastases.
Atalar B; Modlin LA; Choi CY; Adler JR; Gibbs IC; Chang SD; Harsh GR; Li G; Nagpal S; Hanlon A; Soltys SG
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):713-8. PubMed ID: 24054875
[TBL] [Abstract][Full Text] [Related]
25. Stereotactic radiosurgery for intraventricular brain metastases.
Farnia B; Voong KR; Brown PD; Allen PK; Guha-Thakurta N; Prabhu SS; Rao G; Wang Q; Zhao Z; Mahajan A
J Neurosurg; 2014 Dec; 121 Suppl():26-34. PubMed ID: 25434934
[TBL] [Abstract][Full Text] [Related]
26. What is the optimal treatment of large brain metastases? An argument for a multidisciplinary approach.
Choi CY; Chang SD; Gibbs IC; Adler JR; Harsh GR; Atalar B; Lieberson RE; Soltys SG
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):688-93. PubMed ID: 22445007
[TBL] [Abstract][Full Text] [Related]
27. Postoperative stereotactic radiosurgery without whole-brain radiation therapy for brain metastases: potential role of preoperative tumor size.
Hartford AC; Paravati AJ; Spire WJ; Li Z; Jarvis LA; Fadul CE; Rhodes CH; Erkmen K; Friedman J; Gladstone DJ; Hug EB; Roberts DW; Simmons NE
Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):650-5. PubMed ID: 22795806
[TBL] [Abstract][Full Text] [Related]
28. Predicting tumor control after resection bed radiosurgery of brain metastases.
Luther N; Kondziolka D; Kano H; Mousavi SH; Engh JA; Niranjan A; Flickinger JC; Lunsford LD
Neurosurgery; 2013 Dec; 73(6):1001-6; discussion 1006. PubMed ID: 24264235
[TBL] [Abstract][Full Text] [Related]
29. A matched-pair analysis comparing whole-brain radiotherapy plus stereotactic radiosurgery versus surgery plus whole-brain radiotherapy and a boost to the metastatic site for one or two brain metastases.
Rades D; Kueter JD; Pluemer A; Veninga T; Schild SE
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1077-81. PubMed ID: 18707817
[TBL] [Abstract][Full Text] [Related]
30. Is upfront stereotactic radiosurgery a rational treatment option for very elderly patients with brain metastases? A retrospective analysis of 106 consecutive patients age 80 years and older.
Yomo S; Hayashi M
BMC Cancer; 2016 Dec; 16(1):948. PubMed ID: 27978813
[TBL] [Abstract][Full Text] [Related]
31. Comparison Between Surgical Resection and Stereotactic Radiosurgery in Patients with a Single Brain Metastasis from Non-Small Cell Lung Cancer.
Bougie E; Masson-Côté L; Mathieu D
World Neurosurg; 2015 Jun; 83(6):900-6. PubMed ID: 25659803
[TBL] [Abstract][Full Text] [Related]
32. Surgical resection and postoperative radiosurgery versus staged radiosurgery for large brain metastases.
Dohm AE; Hughes R; Wheless W; Lecompte M; Lanier C; Ruiz J; Watabe K; Xing F; Su J; Cramer C; Laxton A; Tatter S; Chan MD
J Neurooncol; 2018 Dec; 140(3):749-756. PubMed ID: 30367382
[TBL] [Abstract][Full Text] [Related]
33. Outcome predictors of Gamma Knife surgery for melanoma brain metastases. Clinical article.
Liew DN; Kano H; Kondziolka D; Mathieu D; Niranjan A; Flickinger JC; Kirkwood JM; Tarhini A; Moschos S; Lunsford LD
J Neurosurg; 2011 Mar; 114(3):769-79. PubMed ID: 20524829
[TBL] [Abstract][Full Text] [Related]
34. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
Rades D; Bohlen G; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
Cancer; 2007 Jun; 109(12):2515-21. PubMed ID: 17487853
[TBL] [Abstract][Full Text] [Related]
35. Gamma knife radiosurgery for the management of cerebral metastases from non-small cell lung cancer.
Bowden G; Kano H; Caparosa E; Park SH; Niranjan A; Flickinger J; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):766-72. PubMed ID: 25658792
[TBL] [Abstract][Full Text] [Related]
36. Reirradiation of brain metastases with radiosurgery.
Maranzano E; Trippa F; Casale M; Costantini S; Anselmo P; Carletti S; Principi M; Caserta C; Loreti F; Giorgi C
Radiother Oncol; 2012 Feb; 102(2):192-7. PubMed ID: 21880387
[TBL] [Abstract][Full Text] [Related]
37. Impact of regular magnetic resonance imaging follow-up after stereotactic radiotherapy to the surgical cavity in patients with one to three brain metastases.
Bachmann N; Leiser D; Ermis E; Vulcu S; Schucht P; Raabe A; Aebersold DM; Herrmann E
Radiat Oncol; 2019 Mar; 14(1):45. PubMed ID: 30871597
[TBL] [Abstract][Full Text] [Related]
38. The results of resection after stereotactic radiosurgery for brain metastases.
Kano H; Kondziolka D; Zorro O; Lobato-Polo J; Flickinger JC; Lunsford LD
J Neurosurg; 2009 Oct; 111(4):825-31. PubMed ID: 19425892
[TBL] [Abstract][Full Text] [Related]
39. Relevance of gamma knife radiosurgery alone for the treatment of non-small cell lung cancer brain metastases.
Zairi F; Ouammou Y; Le Rhun E; Aboukais R; Blond S; Vermandel M; Deken V; Devos P; Reyns N
Clin Neurol Neurosurg; 2014 Oct; 125():87-93. PubMed ID: 25108698
[TBL] [Abstract][Full Text] [Related]
40. Salvage stereotactic radiosurgery effectively treats recurrences from whole-brain radiation therapy.
Chao ST; Barnett GH; Vogelbaum MA; Angelov L; Weil RJ; Neyman G; Reuther AM; Suh JH
Cancer; 2008 Oct; 113(8):2198-204. PubMed ID: 18780319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
